Development Technologies Corp. (DVTC)

Market Cap	105.00M
Revenue	n/a
Net Income	n/a
Shares Out	21.00M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	n/a
Open	5.00
Previous Close	5.00
Day's Range	5.00 - 5.00
52-Week Range	5.00 - 23.00
Beta	3.88
RSI	25.78
Earnings Date	n/a

About Development Technologies

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.

• Industry: Shell Companies
• Sector: Financials
• Founded: 1995
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: DVTC